Zanganeh Maky's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Jul 9, 2024
- Accession no.
- 0001437749-24-022360
- Filed
- Jul 9, 2024
- Trade date
- Jul 3, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zanganeh MakyCIK 0001507650 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | Common Stock | XIn-the-money exerciseAcquired | +60,242 | – | – | 665,153 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +30,121 | – | – | 30,121 | Direct | |
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +30,121 | – | – | 30,121 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.